Investigation of the prevalence of vitamin D deficiency in hospitalized COVID-19 patients and its association with disease severity, outcome, and mortality
et al., Research Square, doi:10.21203/rs.3.rs-8254002/v1, Jan 2026
Vitamin D for COVID-19
8th treatment shown to reduce risk in
October 2020, now with p < 0.00000000001 from 136 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols
combine treatments.
6,300+ studies for
210+ treatments. c19early.org
|
Retrospective 276 hospitalized COVID-19 patients showing higher mortality with vitamin D deficiency. The main analysis found no significant differences in ICU admission, mechanical ventilation, or mortality, however comparing severely deficient patients (<12 ng/ml) to those with optimal levels (>30 ng/ml) showed a significantly increased risk of mortality in the deficient group.
This is the 228th COVID-19 sufficiency study for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001.
|
risk of death, 65.9% lower, OR 0.34, p = 0.04, high D levels (≥30 ng/mL) 91, low D levels (<12 ng/mL) 65, adjusted per study, inverted to make OR<1 favor high D levels (≥30 ng/mL), multivariable, RR approximated with OR.
|
|
risk of mechanical ventilation, 25.9% lower, OR 0.74, p = 0.67, high D levels (≥30 ng/mL) 91, low D levels (<12 ng/mL) 65, adjusted per study, inverted to make OR<1 favor high D levels (≥30 ng/mL), multivariable, RR approximated with OR.
|
|
risk of ICU admission, 47.9% lower, OR 0.52, p = 0.16, high D levels (≥30 ng/mL) 91, low D levels (<12 ng/mL) 65, adjusted per study, inverted to make OR<1 favor high D levels (≥30 ng/mL), multivariable, RR approximated with OR.
|
|
risk of death, 41.2% lower, OR 0.59, p = 0.13, high D levels (≥20 ng/mL) 145, low D levels (<20 ng/mL) 131, adjusted per study, inverted to make OR<1 favor high D levels (≥20 ng/mL), multivariable, RR approximated with OR.
|
|
risk of mechanical ventilation, 34.2% lower, OR 0.66, p = 0.36, high D levels (≥20 ng/mL) 145, low D levels (<20 ng/mL) 131, adjusted per study, inverted to make OR<1 favor high D levels (≥20 ng/mL), multivariable, RR approximated with OR.
|
|
risk of ICU admission, 13.0% lower, OR 0.87, p = 0.68, high D levels (≥20 ng/mL) 145, low D levels (<20 ng/mL) 131, adjusted per study, inverted to make OR<1 favor high D levels (≥20 ng/mL), multivariable, RR approximated with OR.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Zendehdel et al., 12 Jan 2026, retrospective, Iran, preprint, 7 authors, study period 21 March, 2020 - 11 September, 2020.
Contact: dr.zendedel.a@gmail.com, md.sekhavatimoghadam@gmail.com, z.afard1979@gmail.com, md.b.hadian@gmail.com, abol.akbarzadeh@gmail.com, md.ghasemazimi@gmail.com, md.a.asoodeh@gmail.com.
Investigation of the prevalence of vitamin D de ciency in hospitalized COVID-19 patients and its association with disease severity, outcome, and mortality
Background: In this study, we aimed to assess the prevalence of vitamin D deficiency in hospitalized Covid-19 patients and demonstrate its association with severity and mortality of the disease. Methods: This observational study at Ziaeian Hospital, Tehran, Iran. Of all confirmed COVID-19 patients who were admitted to this hospital 276 patients were enrolled in this study and divided into two groups; 145 patients in group1 with a serum 25(OH)D level >20 ng/ml and 131 patients in group 2 with a serum 25 (OH)D level =<20 ng/ml. The severity, outcome, and mortality of COVID-19 disease were compared in these two groups, based on chest CT scans findings, laboratory data, and patient' vital signs on admission day, and the duration of hospitalization, requirement to ICU admission, need for intubation, and mortality. Results: The prevalence of vitamin D deficiency was 22.1 %, and vitamin D insufficiency by definition of serum 25(OH)D levels 12-20 ng/ml was 25.4%. Despite, an increase in serum levels of CPK, Ferritin, LDH, CRP, Ddimer, AST, and ALT, there was not any significant relationship between serum level of 25(OH)D with laboratory tests, chest CT scan scores, and patient's vital signs on admission day by univariate and multivariate analysis. The odds of incidence of ICU admission, mechanical ventilation, and mortality were higher in group 2 which was not statistically significant by univariate and multivariate analysis. Still, the mortality was significantly higher in subgroup 2 by multivariate regression analysis.
Conclusion: This study showed that vitamin D deficiency was associated with a higher mortality rate, while could not show any significant association between serum 25(OH)D levels with the incidence of ICU admission, need for mechanical ventilation, and length of hospital stay, also we did not find any significant relationship with laboratory tests, radiologic findings, and patient's vital signs on admission day.
Conflict of interest The author has no conflict of interest in any terms during the study to declare Supplementary Files This is a list of supplementary les associated with this preprint. Click to download.
Figure.png
References
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity, Journal of infection and public health
Alsafar, Grant, Hijazi, Uddin, Alkaabi et al., COVID-19 disease severity and death in relation to vitamin D status among SARS-CoV-2-positive UAE residents, Nutrients
Assistant, COVID-19 imaging findings
Başaran, Adaş, Gökden, Turgut, Yıldırmak et al., The relationship between vitamin D and the severity of COVID-19, Bratislava Medical Journal-Bratislavske Lekarske Listy
Borsche, Glauner, Jv, COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25 (OH) D3: Results of a systematic review and meta-analysis, Nutrients
Campi, Gennari, Merlotti, Mingiano, Frosali et al., Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infectious Diseases
Cannell, Vieth, Umhau, Holick, Grant et al., Epidemic influenza and vitamin D, Epidemiology & Infection
Dawson-Hughes, Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment
Diabetes, Vitamin D and COVID-19: why the controversy
Esmaeili, Mohammadian, Radbakhsh, Momtazi-Borojeni, Parizi et al., Evaluation of vitamin D(3) deficiency: A population-based study in northeastern Iran, J Cell Biochem
Fang, Zhang, Xie, Lin, Ying et al., Sensitivity of chest CT for COVID-19: comparison to RT-PCR, Radiology
Ginde, Mansbach, Camargo, Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey, Archives of internal medicine
Group, Genomewide association study of severe Covid-19 with respiratory failure, New England Journal of Medicine
Hastie, Pell, Sattar, Vitamin D and COVID-19 infection and mortality in UK Biobank, European Journal of Nutrition
Holick, Vitamin D deficiency, New England journal of medicine
Kazemi, Mohammadi, Aghababaee, Golzarand, Clark et al., Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis, Advances in Nutrition
Kupferschmidt, Cohen, Race to find COVID-19 treatments accelerates, American Association for the Advancement of Science
Lohia, Nguyen, Patel, Kapur, Exploring the link between vitamin D and clinical outcomes in COVID-19, American Journal of Physiology-Endocrinology and Metabolism
Margarucci, Montanari, Gianfranceschi, Caprara, Valeriani et al., The role of vitamin D in prevention of COVID-19 and its severity: an umbrella review, Acta Bio Medica: Atenei Parmensis
Oristrell, Oliva, Casado, Subirana, Domínguez et al., Vitamin D supplementation and COVID-19 risk: A population-based, cohort study, Journal of endocrinological investigation
Panovska-Stavridis, Ridova, Stojanoska, Demiri, Stevanovic et al., Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management, prilozi
Pazirandeh, Burns, Overview of vitamin D 2021
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients
Rastad, Gorabi, Qorbani, Seif, Asayesh et al., Prevalence and determinants of vitamin D deficiency in Iranian children and adolescents: the CASPIAN-V study, Journal of Diabetes & Metabolic Disorders
Roger Bouillon, Phd, Frcp, Vitamin D and extraskeletal health
Roth, Jones, Prosser, Robinson, Vohra, Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood, The Journal of infectious diseases
Smolders, Van Den Ouweland, Geven, Pickkers, Kox, Vitamin D deficiency in COVID-19: Mixing up cause and consequence, Metabolism-Clinical and Experimental
Thacher, Vitamin, Mayo Clinic Proceedings
Wortsman, Matsuoka, Chen, Lu, Holick, Decreased bioavailability of vitamin D in obesity, The American journal of clinical nutrition
Xu, Baylink, Chen, Reeves, Xiao et al., The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19, Journal of translational medicine
Zendedel, Gholami, Anbari, Ghanadi, Bachari et al., Effects of vitaminn D intake on FEV1 and COPD exacerbation : a randomized clinical trial study, Global journal of health science
Zendehdel, Jamalimoghaddamsiyahkali, Bidkhori, Ansari, Asoodeh, The Role of Underlying Diseases on Covid-19 Severity and Mortality among Hospitalized Patients: a single-center, retrospective, cohort study
DOI record:
{
"DOI": "10.21203/rs.3.rs-8254002/v1",
"URL": "http://dx.doi.org/10.21203/rs.3.rs-8254002/v1",
"abstract": "<title>Abstract</title>\n <p>Background\n In this study, we aimed to assess the prevalence of vitamin D deficiency in hospitalized Covid-19 patients and demonstrate its association with severity and mortality of the disease.\nMethods\n This observational study at Ziaeian Hospital, Tehran, Iran. Of all confirmed COVID-19 patients who were admitted to this hospital 276 patients were enrolled in this study and divided into two groups; 145 patients in group1 with a serum 25(OH)D level > 20 ng/ml and 131 patients in group 2 with a serum 25 (OH)D level = < 20 ng/ml. The severity, outcome, and mortality of COVID-19 disease were compared in these two groups, based on chest CT scans findings, laboratory data, and patient' vital signs on admission day, and the duration of hospitalization, requirement to ICU admission, need for intubation, and mortality.\nResults\n The prevalence of vitamin D deficiency was 22.1%, and vitamin D insufficiency by definition of serum 25(OH)D levels 12–20 ng/ml was 25.4%. Despite, an increase in serum levels of CPK, Ferritin, LDH, CRP, D-dimer, AST, and ALT, there was not any significant relationship between serum level of 25(OH)D with laboratory tests, chest CT scan scores, and patient's vital signs on admission day by univariate and multivariate analysis. The odds of incidence of ICU admission, mechanical ventilation, and mortality were higher in group 2 which was not statistically significant by univariate and multivariate analysis. Still, the mortality was significantly higher in subgroup 2 by multivariate regression analysis.\nConclusion\n This study showed that vitamin D deficiency was associated with a higher mortality rate, while could not show any significant association between serum 25(OH)D levels with the incidence of ICU admission, need for mechanical ventilation, and length of hospital stay, also we did not find any significant relationship with laboratory tests, radiologic findings, and patient's vital signs on admission day.</p>",
"accepted": {
"date-parts": [
[
2025,
12,
1
]
]
},
"author": [
{
"affiliation": [
{
"name": "Tehran University of Medical Sciences"
}
],
"family": "Zendehdel",
"given": "Abolfazl",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Tehran University of Medical Sciences"
}
],
"family": "JamaliMoghaddamsiyahkali",
"given": "SaeidReza",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Tehran University of Medical Sciences"
}
],
"family": "Aghsaeifard",
"given": "Ziba",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Tehran University of Medical Sciences"
}
],
"family": "Bidkhori",
"given": "Mohammad",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Tehran University of Medical Sciences"
}
],
"family": "Nuhu",
"given": "Muhammad Abubakar",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Tehran University of Medical Sciences"
}
],
"family": "Azimi",
"given": "Ghasem",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Tehran University of Medical Sciences"
}
],
"family": "Asoodeh",
"given": "Azadeh",
"sequence": "additional"
}
],
"container-title": [],
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2026,
1,
12
]
],
"date-time": "2026-01-12T06:20:41Z",
"timestamp": 1768198841000
},
"deposited": {
"date-parts": [
[
2026,
1,
12
]
],
"date-time": "2026-01-12T06:20:46Z",
"timestamp": 1768198846000
},
"group-title": "In Review",
"indexed": {
"date-parts": [
[
2026,
1,
12
]
],
"date-time": "2026-01-12T09:31:04Z",
"timestamp": 1768210264051,
"version": "3.49.0"
},
"institution": [
{
"name": "Research Square"
}
],
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2026,
1,
12
]
]
},
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "unspecified",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2026,
1,
12
]
],
"date-time": "2026-01-12T00:00:00Z",
"timestamp": 1768176000000
}
}
],
"link": [
{
"URL": "https://www.researchsquare.com/article/rs-8254002/v1",
"content-type": "text/html",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.researchsquare.com/article/rs-8254002/v1.html",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "297",
"original-title": [],
"posted": {
"date-parts": [
[
2026,
1,
12
]
]
},
"prefix": "10.21203",
"published": {
"date-parts": [
[
2026,
1,
12
]
]
},
"publisher": "Springer Science and Business Media LLC",
"reference": [
{
"author": "Kupferschmidt K",
"key": "ref1",
"unstructured": "Kupferschmidt K, Cohen J. Race to find COVID-19 treatments accelerates. American Association for the Advancement of Science; 2020.",
"volume-title": "Race to find COVID-19 treatments accelerates",
"year": "2020"
},
{
"DOI": "10.1007/s40618-021-01639-9",
"article-title": "Vitamin D supplementation and COVID-19 risk: A population-based, cohort study",
"author": "Oristrell J",
"doi-asserted-by": "crossref",
"first-page": "167",
"issue": "1",
"journal-title": "J Endocrinol Investig",
"key": "ref2",
"unstructured": "Oristrell J, Oliva J, Casado E, Subirana I, Domínguez D, Toloba A, et al. Vitamin D supplementation and COVID-19 risk: A population-based, cohort study. J Endocrinol Investig. 2022;45(1):167–79.",
"volume": "45",
"year": "2022"
},
{
"article-title": "The role of vitamin D in prevention of COVID-19 and its severity: an umbrella review",
"author": "Margarucci LM",
"journal-title": "Acta Bio Medica: Atenei Parmensis",
"key": "ref3",
"unstructured": "Margarucci LM, Montanari E, Gianfranceschi G, Caprara C, Valeriani F, Piccolella A et al. The role of vitamin D in prevention of COVID-19 and its severity: an umbrella review. Acta Bio Medica: Atenei Parmensis. 2021;92(Suppl 6).",
"volume": "92",
"year": "2021"
},
{
"article-title": "The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19",
"author": "Xu Y",
"first-page": "1",
"issue": "1",
"journal-title": "J translational Med",
"key": "ref4",
"unstructured": "Xu Y, Baylink DJ, Chen C-S, Reeves ME, Xiao J, Lacy C, et al. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J translational Med. 2020;18(1):1–12.",
"volume": "18",
"year": "2020"
},
{
"author": "Zendehdel A",
"key": "ref5",
"unstructured": "Zendehdel A, JamaliMoghaddamsiyahkali S, Bidkhori M, Ansari M, Asoodeh A. The Role of Underlying Diseases on Covid-19 Severity and Mortality among Hospitalized Patients: a single-center, retrospective, cohort study. Endocrine, Metabolic & Immune Disorders - Drug Targets; 2021.",
"volume-title": "The Role of Underlying Diseases on Covid-19 Severity and Mortality among Hospitalized Patients: a single-center, retrospective, cohort study",
"year": "2021"
},
{
"DOI": "10.1016/j.mayocp.2021.02.014",
"doi-asserted-by": "crossref",
"key": "ref6",
"unstructured": "Thacher TD, editor. Vitamin D and COVID-19. Mayo Clinic Proceedings; 2021: Elsevier."
},
{
"key": "ref7",
"unstructured": "Iranian Ministry of Health and Medical Education. Diagnostic and therapeutic flowchart of COVID 19 disease at the outpatient and inpatient service levels ed. national guidelines for novel corona virus. national guidelines for novel corona virus. 2022."
},
{
"DOI": "10.1093/ajcn/72.3.690",
"article-title": "Decreased bioavailability of vitamin D in obesity",
"author": "Wortsman J",
"doi-asserted-by": "crossref",
"first-page": "690",
"issue": "3",
"journal-title": "Am J Clin Nutr",
"key": "ref8",
"unstructured": "Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3.",
"volume": "72",
"year": "2000"
},
{
"DOI": "10.1186/s12879-021-06281-7",
"article-title": "Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy",
"author": "Campi I",
"doi-asserted-by": "crossref",
"first-page": "1",
"issue": "1",
"journal-title": "BMC Infect Dis",
"key": "ref9",
"unstructured": "Campi I, Gennari L, Merlotti D, Mingiano C, Frosali A, Giovanelli L, et al. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infect Dis. 2021;21(1):1–13.",
"volume": "21",
"year": "2021"
},
{
"DOI": "10.1001/archinternmed.2008.560",
"article-title": "Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey",
"author": "Ginde AA",
"doi-asserted-by": "crossref",
"first-page": "384",
"issue": "4",
"journal-title": "Arch Intern Med",
"key": "ref10",
"unstructured": "Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169(4):384–90.",
"volume": "169",
"year": "2009"
},
{
"DOI": "10.5539/gjhs.v7n4p243",
"article-title": "Effects of vitaminn D intake on FEV1 and COPD exacerbation: a randomized clinical trial study",
"author": "Zendedel A",
"doi-asserted-by": "crossref",
"journal-title": "Global J health Sci",
"key": "ref11",
"unstructured": "Zendedel A, Gholami M, Anbari K, Ghanadi K, Ceneicel Bachari E, Azargon A. Effects of vitaminn D intake on FEV1 and COPD exacerbation: a randomized clinical trial study. Global J health Sci. 2015.",
"year": "2015"
},
{
"author": "Sassan Pazirandeh M",
"key": "ref12",
"unstructured": "Sassan Pazirandeh M, David L, Burns M. Overview of vitamin D 2021 [updated Sep 23, 2021. 2:[Available from: https://www3.utdos.ir/contents/vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment?search=vitamin%20d§ionRank=3&usage_type=default&anchor=H20&source=machineLearning&selectedTitle=2~146&display_rank=1#H20",
"year": "2021"
},
{
"DOI": "10.1056/NEJMra070553",
"article-title": "Vitamin D deficiency",
"author": "Holick MF",
"doi-asserted-by": "crossref",
"first-page": "266",
"issue": "3",
"journal-title": "N Engl J Med",
"key": "ref13",
"unstructured": "Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.",
"volume": "357",
"year": "2007"
},
{
"DOI": "10.3390/nu12092757",
"article-title": "Vitamin D deficiency and outcome of COVID-19 patients",
"author": "Radujkovic A",
"doi-asserted-by": "crossref",
"first-page": "2757",
"issue": "9",
"journal-title": "Nutrients",
"key": "ref14",
"unstructured": "Radujkovic A, Hippchen T, Tiwari-Heckler S, Dreher S, Boxberger M, Merle U. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients. 2020;12(9):2757.",
"volume": "12",
"year": "2020"
},
{
"author": "Roger Bouillon M",
"key": "ref15",
"unstructured": "Roger Bouillon M, PhD FRCP, Vitamin D. and extraskeletal health 2021 [updated Feb 22, 2021. 2:[Available from: https://www3.utdos.ir/contents/vitamin-d-and-extraskeletal-health?search=vitamin%20d&source=search_result&selectedTitle=5~146&usage_type=default&display_rank=4",
"year": "2021"
},
{
"author": "Diabetes TL",
"first-page": "53",
"key": "ref16",
"unstructured": "Diabetes TL. Vitamin D and COVID-19: why the controversy? Elsevier; 2021. p. 53.",
"volume-title": "Vitamin D and COVID-19: why the controversy?",
"year": "2021"
},
{
"DOI": "10.1016/j.metabol.2020.154434",
"article-title": "Vitamin D deficiency in COVID-19: Mixing up cause and consequence",
"author": "Smolders J",
"doi-asserted-by": "crossref",
"journal-title": "Metabolism-Clinical Experimental",
"key": "ref17",
"unstructured": "Smolders J, van den Ouweland J, Geven C, Pickkers P, Kox M. Vitamin D deficiency in COVID-19: Mixing up cause and consequence. Metabolism-Clinical Experimental. 2021;115.",
"volume": "115",
"year": "2021"
},
{
"DOI": "10.3390/nu13051714",
"article-title": "COVID-19 disease severity and death in relation to vitamin D status among SARS-CoV-2-positive UAE residents",
"author": "AlSafar H",
"doi-asserted-by": "crossref",
"first-page": "1714",
"issue": "5",
"journal-title": "Nutrients",
"key": "ref18",
"unstructured": "AlSafar H, Grant WB, Hijazi R, Uddin M, Alkaabi N, Tay G, et al. COVID-19 disease severity and death in relation to vitamin D status among SARS-CoV-2-positive UAE residents. Nutrients. 2021;13(5):1714.",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.1152/ajpendo.00517.2020",
"article-title": "Exploring the link between vitamin D and clinical outcomes in COVID-19",
"author": "Lohia P",
"doi-asserted-by": "crossref",
"first-page": "E520",
"issue": "3",
"journal-title": "Am J Physiology-Endocrinology Metabolism",
"key": "ref19",
"unstructured": "Lohia P, Nguyen P, Patel N, Kapur S. Exploring the link between vitamin D and clinical outcomes in COVID-19. Am J Physiology-Endocrinology Metabolism. 2021;320(3):E520–6.",
"volume": "320",
"year": "2021"
},
{
"DOI": "10.1007/s00394-020-02372-4",
"article-title": "Vitamin D and COVID-19 infection and mortality in UK Biobank",
"author": "Hastie CE",
"doi-asserted-by": "crossref",
"first-page": "545",
"issue": "1",
"journal-title": "Eur J Nutr",
"key": "ref20",
"unstructured": "Hastie CE, Pell JP, Sattar N. Vitamin D and COVID-19 infection and mortality in UK Biobank. Eur J Nutr. 2021;60(1):545–8.",
"volume": "60",
"year": "2021"
},
{
"DOI": "10.1148/radiol.2020200432",
"article-title": "Sensitivity of chest CT for COVID-19: comparison to RT-PCR",
"author": "Fang Y",
"doi-asserted-by": "crossref",
"first-page": "E115",
"issue": "2",
"journal-title": "Radiology",
"key": "ref21",
"unstructured": "Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;296(2):E115–7.",
"volume": "296",
"year": "2020"
},
{
"author": "Bess Dawson-Hughes M",
"key": "ref22",
"unstructured": "Bess Dawson-Hughes M. Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment 2021 [2:[Available from: https://www3.utdos.ir/contents/vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment?search=vitamin%20d&source=search_result&selectedTitle=2~146&usage_type=default&display_rank=."
},
{
"author": "Assistant R",
"key": "ref23",
"unstructured": "Assistant R. COVID-19 imaging findings. Rediology Assistant. 2020.",
"year": "2020"
},
{
"DOI": "10.2478/prilozi-2021-0001",
"article-title": "Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021)",
"author": "Panovska-Stavridis I",
"doi-asserted-by": "crossref",
"issue": "1",
"journal-title": "prilozi",
"key": "ref24",
"unstructured": "Panovska-Stavridis I, Ridova N, Stojanoska T, Demiri I, Stevanovic M, Stojanovska S et al. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). prilozi. 2021;42(1).",
"volume": "42",
"year": "2021"
},
{
"DOI": "10.1017/S0950268806007175",
"article-title": "Epidemic influenza and vitamin D",
"author": "Cannell J",
"doi-asserted-by": "crossref",
"first-page": "1129",
"issue": "6",
"journal-title": "Epidemiol Infect",
"key": "ref25",
"unstructured": "Cannell J, Vieth R, Umhau J, Holick M, Grant W, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129–40.",
"volume": "134",
"year": "2006"
},
{
"DOI": "10.1007/s40200-021-00757-8",
"article-title": "Prevalence and determinants of vitamin D deficiency in Iranian children and adolescents: the CASPIAN-V study",
"author": "Rastad H",
"doi-asserted-by": "crossref",
"first-page": "383",
"issue": "1",
"journal-title": "J Diabetes Metabolic Disorders",
"key": "ref26",
"unstructured": "Rastad H, Mahdavi Gorabi A, Qorbani M, Seif E, Asayesh H, Motlagh ME, et al. Prevalence and determinants of vitamin D deficiency in Iranian children and adolescents: the CASPIAN-V study. J Diabetes Metabolic Disorders. 2021;20(1):383–9.",
"volume": "20",
"year": "2021"
},
{
"DOI": "10.1002/jcb.28317",
"article-title": "Evaluation of vitamin D(3) deficiency: A population-based study in northeastern Iran",
"author": "Esmaeili SA",
"doi-asserted-by": "crossref",
"first-page": "10337",
"issue": "6",
"journal-title": "J Cell Biochem",
"key": "ref27",
"unstructured": "Esmaeili SA, Mohammadian S, Radbakhsh S, Momtazi-Borojeni AA, Kheirmand Parizi P, Atabati H, et al. Evaluation of vitamin D(3) deficiency: A population-based study in northeastern Iran. J Cell Biochem. 2019;120(6):10337–41.",
"volume": "120",
"year": "2019"
},
{
"DOI": "10.3390/nu13103596",
"article-title": "COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25 (OH) D3: Results of a systematic review and meta-analysis",
"author": "Borsche L",
"doi-asserted-by": "crossref",
"first-page": "3596",
"issue": "10",
"journal-title": "Nutrients",
"key": "ref28",
"unstructured": "Borsche L, Glauner B, Mendel Jv. COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25 (OH) D3: Results of a systematic review and meta-analysis. Nutrients. 2021;13(10):3596.",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.1093/advances/nmab012",
"article-title": "Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis",
"author": "Kazemi A",
"doi-asserted-by": "crossref",
"first-page": "1636",
"issue": "5",
"journal-title": "Adv Nutr",
"key": "ref29",
"unstructured": "Kazemi A, Mohammadi V, Aghababaee SK, Golzarand M, Clark CC, Babajafari S. Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis. Adv Nutr. 2021;12(5):1636–58.",
"volume": "12",
"year": "2021"
},
{
"author": "Başaran N",
"key": "ref30",
"unstructured": "Başaran N, Adaş M, Gökden Y, Turgut N, Yıldırmak T, Güntaş G. The relationship between vitamin D and the severity of COVID-19. Bratislava Medical Journal-Bratislavske Lekarske Listy; 2021.",
"volume-title": "The relationship between vitamin D and the severity of COVID-19",
"year": "2021"
},
{
"DOI": "10.1016/j.jiph.2020.06.021",
"article-title": "Role of vitamin D in preventing of COVID-19 infection, progression and severity",
"author": "Ali N",
"doi-asserted-by": "crossref",
"first-page": "1373",
"issue": "10",
"journal-title": "J Infect Public Health",
"key": "ref31",
"unstructured": "Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health. 2020;13(10):1373–80.",
"volume": "13",
"year": "2020"
},
{
"DOI": "10.1086/527488",
"article-title": "Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood",
"author": "Roth DE",
"doi-asserted-by": "crossref",
"first-page": "676",
"issue": "5",
"journal-title": "J Infect Dis",
"key": "ref32",
"unstructured": "Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J Infect Dis. 2008;197(5):676–80.",
"volume": "197",
"year": "2008"
},
{
"DOI": "10.1056/NEJMoa2020283",
"article-title": "Genomewide association study of severe Covid-19 with respiratory failure",
"author": "Group SC-G",
"doi-asserted-by": "crossref",
"first-page": "1522",
"issue": "16",
"journal-title": "N Engl J Med",
"key": "ref33",
"unstructured": "Group SC-G. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383(16):1522–34.",
"volume": "383",
"year": "2020"
}
],
"reference-count": 33,
"references-count": 33,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.researchsquare.com/article/rs-8254002/v1"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"subtype": "preprint",
"title": "Investigation of the prevalence of vitamin D deficiency in hospitalized COVID-19 patients and its association with disease severity, outcome, and mortality",
"type": "posted-content"
}
